Preliminary Evaluation of Potential Disease Modification by Hylan G-F 20 (Synvisc^®) Using dGEMRIC

Pottumarthi V. Prasad^1*, Wei Li¹, Thomas Schnitzer², Nitya Krishnan³ and Deborah Burstein³

¹NorthShore University HealthSystem, Evanston, IL, USA

²Northwestern University’s Feinberg School of Medicine, Chicago, IL, USA

³Beth Israel Deaconess Medical Center, Boston, MA, USA

^*Corresponding Author: Dr. Pottumarthi V. Prasad, PhD, NorthShore University HealthSystem, 2650 Ridge Avenue, Walgreen Jr. Bldg., Suite G-507, Evanston, IL 60201, USA, Tel: 847-570-1349 Email: